SGO1 and sarcoma: We observed that high expression levels of SGO1 are significantly related poorer overall survival (OS) in most cancers, including ACC, KIRP, KIRC, LIHC, LGG (brain lower grade glioma), LUAD, MESO (mesothelioma), PAAD, SKCM, and SARC (sarcoma) (Figure 3A-J).